{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T19:50:25Z","timestamp":1742932225373,"version":"3.40.3"},"publisher-location":"Cham","reference-count":22,"publisher":"Springer Nature Switzerland","isbn-type":[{"type":"print","value":"9783031646355"},{"type":"electronic","value":"9783031646362"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-3-031-64636-2_3","type":"book-chapter","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T06:02:27Z","timestamp":1724738547000},"page":"31-41","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Screening for Age-Related Macular Degeneration: A Cost-Effectiveness Evaluation"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6394-3733","authenticated-orcid":false,"given":"Ond\u0159ej","family":"Gajdo\u0161","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9540-9525","authenticated-orcid":false,"given":"Martina","family":"Hol\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0558-9438","authenticated-orcid":false,"given":"Vojt\u011bch","family":"Kamensk\u00fd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Havelkov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,28]]},"reference":[{"key":"3_CR1","unstructured":"\u0160trofov\u00e1, H., Varcholov\u00e1, D., Sedl\u00e1\u010dek, K., \u0160vancarov\u00e1, R.: St\u00e1rnut\u00ed oka a v\u011bkem podm\u00edn\u011bn\u00e1 makul\u00e1rn\u00ed degenerace. 13, 209\u2013213 (2011)"},{"key":"3_CR2","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1001\/jamaophthalmol.2013.6636","volume":"132","author":"EY Chew","year":"2014","unstructured":"Chew, E.Y., et al.: Ten-year follow-up of age-related macular degeneration in the age-related eye disease study. JAMA Ophthalmol. 132, 272 (2014). https:\/\/doi.org\/10.1001\/jamaophthalmol.2013.6636","journal-title":"JAMA Ophthalmol."},{"key":"3_CR3","doi-asserted-by":"publisher","first-page":"e011504","DOI":"10.1136\/bmjopen-2016-011504","volume":"6","author":"DJ Taylor","year":"2016","unstructured":"Taylor, D.J., Hobby, A.E., Binns, A.M., Crabb, D.P.: How does age-related macular degeneration affect real-world visual ability and quality of life? A systematic review. BMJ Open. 6, e011504 (2016). https:\/\/doi.org\/10.1136\/bmjopen-2016-011504","journal-title":"A systematic review. BMJ Open."},{"key":"3_CR4","doi-asserted-by":"publisher","unstructured":"\u0160iaudvytyt\u0117, L., Mitkut\u0117, D., Bal\u010di\u016bnien\u0117, J.: Quality of life in patients with age-related macular degeneration. Medicina (B. Aires). 48, 15 (2012). https:\/\/doi.org\/10.3390\/medicina48020015","DOI":"10.3390\/medicina48020015"},{"key":"3_CR5","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/00019442-200205000-00010","volume":"10","author":"BW Rovner","year":"2002","unstructured":"Rovner, B.W., Casten, R.J.: Activity loss and depression in age-related macular degeneration. Am. J. Geriatr. Psychiatry 10, 305\u2013310 (2002). https:\/\/doi.org\/10.1097\/00019442-200205000-00010","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"3_CR6","doi-asserted-by":"publisher","first-page":"e0133628","DOI":"10.1371\/journal.pone.0133628","volume":"10","author":"H Tamura","year":"2015","unstructured":"Tamura, H., Goto, R., Akune, Y., Hiratsuka, Y., Hiragi, S., Yamada, M.: The clinical effectiveness and cost-effectiveness of screening for age-related macular degeneration in Japan: a markov modeling study. PLoS One 10, e0133628 (2015). https:\/\/doi.org\/10.1371\/journal.pone.0133628","journal-title":"PLoS ONE"},{"key":"3_CR7","unstructured":"Shanahan, C.: The Economic Benefits of Using Lutein and Zeaxanthin Food Supplements in the European Union (2017)"},{"key":"3_CR8","unstructured":"TreeAge Software: TreeAge Pro, R2.1. http:\/\/www.treeage.com (2020)"},{"key":"3_CR9","unstructured":"Statn\u00ed \u00fastav pro kontrolu l\u00e9\u010div: Postup pro posuzov\u00e1n\u00ed anal\u00fdzy n\u00e1kladov\u00e9 efektivity. Praha (2022)"},{"key":"3_CR10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12913-018-2836-0","volume":"18","author":"L Pezzullo","year":"2018","unstructured":"Pezzullo, L., Streatfeild, J., Simkiss, P., Shickle, D.: The economic impact of sight loss and blindness in the UK adult population. BMC Health Serv. Res. 18, 63 (2018). https:\/\/doi.org\/10.1186\/s12913-018-2836-0","journal-title":"BMC Health Serv. Res."},{"key":"3_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/4691276","volume":"2016","author":"D Green","year":"2016","unstructured":"Green, D., et al.: The cost of blindness in the Republic of Ireland 2010\u20132020. J. Ophthalmol. 2016, 1\u20138 (2016). https:\/\/doi.org\/10.1155\/2016\/4691276","journal-title":"J. Ophthalmol."},{"key":"3_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/09286586.2017.1281426","volume":"24","author":"U Chakravarthy","year":"2017","unstructured":"Chakravarthy, U., Biundo, E., Saka, R.O., Fasser, C., Bourne, R., Little, J.-A.: The economic impact of blindness in Europe. Ophthalmic Epidemiol. 24, 239\u2013247 (2017). https:\/\/doi.org\/10.1080\/09286586.2017.1281426","journal-title":"Ophthalmic Epidemiol."},{"key":"3_CR13","first-page":"473","volume":"97","author":"GC Brown","year":"1999","unstructured":"Brown, G.C.: Vision and quality-of-life. Trans. Am. Ophthalmol. Soc. 97, 473\u2013511 (1999)","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"3_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1001\/archopht.118.1.47","volume":"118","author":"GC Brown","year":"2000","unstructured":"Brown, G.C.: Utility values and age-related macular degeneration. Arch. Ophthalmol. 118, 47 (2000). https:\/\/doi.org\/10.1001\/archopht.118.1.47","journal-title":"Arch. Ophthalmol."},{"key":"3_CR15","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1136\/bjo.85.10.1153","volume":"85","author":"Y Oshima","year":"2001","unstructured":"Oshima, Y.: Prevalence of age related maculopathy in a representative Japanese population: the Hisayama study. Br. J. Ophthalmol. 85, 1153\u20131157 (2001). https:\/\/doi.org\/10.1136\/bjo.85.10.1153","journal-title":"Br. J. Ophthalmol."},{"key":"3_CR16","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1016\/j.ophtha.2013.03.046","volume":"120","author":"S Rofagha","year":"2013","unstructured":"Rofagha, S., Bhisitkul, R.B., Boyer, D.S., Sadda, S.R., Zhang, K.: Seven-year outcomes in Ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON. Ophthalmology 120, 2292\u20132299 (2013). https:\/\/doi.org\/10.1016\/j.ophtha.2013.03.046","journal-title":"Ophthalmology"},{"key":"3_CR17","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ajo.2007.10.004","volume":"145","author":"CD Regillo","year":"2008","unstructured":"Regillo, C.D., et al.: Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER study year 1. Am. J. Ophthalmol. 145, 239\u2013248.e5 (2008). https:\/\/doi.org\/10.1016\/j.ajo.2007.10.004","journal-title":"Am. J. Ophthalmol."},{"key":"3_CR18","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.ajo.2007.12.029","volume":"145","author":"AN Antoszyk","year":"2008","unstructured":"Antoszyk, A.N., Tuomi, L., Chung, C.Y., Singh, A.: Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration (FOCUS): year 2 results. Am. J. Ophthalmol. 145, 862\u2013874.e3 (2008). https:\/\/doi.org\/10.1016\/j.ajo.2007.12.029","journal-title":"Am. J. Ophthalmol."},{"key":"3_CR19","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1016\/j.ophtha.2015.06.050","volume":"122","author":"CKW Chan","year":"2015","unstructured":"Chan, C.K.W., Gangwani, R.A., McGhee, S.M., Lian, J., Wong, D.S.H.: Cost-effectiveness of screening for intermediate age-related macular degeneration during diabetic retinopathy screening. Ophthalmology 122, 2278\u20132285 (2015). https:\/\/doi.org\/10.1016\/j.ophtha.2015.06.050","journal-title":"Ophthalmology"},{"key":"3_CR20","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1177\/0272989X08327491","volume":"29","author":"J Karnon","year":"2009","unstructured":"Karnon, J., Czoski-Murray, C., Smith, K.J., Brand, C.: A hybrid cohort individual sampling natural history model of age-related macular degeneration: assessing the cost-effectiveness of screening using probabilistic calibration. Med. Decis. Mak. 29, 304\u2013316 (2009). https:\/\/doi.org\/10.1177\/0272989X08327491","journal-title":"Med. Decis. Mak."},{"key":"3_CR21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1177\/0272989X07309638","volume":"28","author":"L Bojke","year":"2008","unstructured":"Bojke, L., Claxton, K., Sculpher, M.J., Palmer, S.: Identifying research priorities: the value of information associated with repeat screening for age-related macular degeneration. Med. Decis. Mak. 28, 33\u201343 (2008). https:\/\/doi.org\/10.1177\/0272989X07309638","journal-title":"Med. Decis. Mak."},{"key":"3_CR22","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s10198-002-0104-y","volume":"3","author":"J Bonastre","year":"2002","unstructured":"Bonastre, J., Le Pen, C., Anderson, P., Ganz, A., Berto, P., Berdeaux, G.: The epidemiology, economics and quality of life burden of age-related macular degeneration in France, Germany, Italy and the United Kingdom. Eur. J. Heal. Econ. 3, 94\u2013102 (2002). https:\/\/doi.org\/10.1007\/s10198-002-0104-y","journal-title":"Eur. J. Heal. Econ."}],"container-title":["Lecture Notes in Computer Science","Bioinformatics and Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-64636-2_3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T10:03:55Z","timestamp":1728986635000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-64636-2_3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9783031646355","9783031646362"],"references-count":22,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-64636-2_3","relation":{},"ISSN":["0302-9743","1611-3349"],"issn-type":[{"type":"print","value":"0302-9743"},{"type":"electronic","value":"1611-3349"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"28 August 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"IWBBIO","order":1,"name":"conference_acronym","label":"Conference Acronym","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"International Work-Conference on Bioinformatics and Biomedical Engineering","order":2,"name":"conference_name","label":"Conference Name","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Gran Canaria","order":3,"name":"conference_city","label":"Conference City","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Spain","order":4,"name":"conference_country","label":"Conference Country","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"2024","order":5,"name":"conference_year","label":"Conference Year","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"15 July 2024","order":7,"name":"conference_start_date","label":"Conference Start Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"17 July 2024","order":8,"name":"conference_end_date","label":"Conference End Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"11","order":9,"name":"conference_number","label":"Conference Number","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"iwbbio2024","order":10,"name":"conference_id","label":"Conference ID","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"https:\/\/iwbbio.ugr.es\/","order":11,"name":"conference_url","label":"Conference URL","group":{"name":"ConferenceInfo","label":"Conference Information"}}]}}